Moreover, we observed that assay cross-reactivity was reliant on the functionalization site of the competitor derivative.
Taken together, these data demonstrate the potential for two complementary imaging paradigms that assay dynamic changes in TSPO levels in vivo.
It was found that assay of lipase activity on this film were most suitable at temperatures between 30 and 40 °C.
The PubChem Bioassay database is a large public bioactivity database, making it prudent to select data so that assay conditions should minimally bias the conclusions of this study.
It was found that assay ranged from 98.13 101.95% for Lamivudine, 98.25 102.84 for TDF, both were within the in-house assay specification of 95 to 105%.
Studies to improve the assay performance in the field were performed, showing that assay activity could be preserved for up to 2 months.
Results also show that assay by stem wounding does not give reliable results in the case of Xap, and that pathogenicity assays by dipping should be preferred.
A critical review of the available in vivo methods that assay cardiac volume (echocardiography, conductance volumetry, sonomicrometry, magnetic resonance imaging) pressure (micromanometers), flow (Doppler echocardiography), and bioelectricity (electrophysiologic studies) are presented.
The validation results showed that assay accuracy, specificity, precision, linearity, and range were suitable for the intended use of ensuring lot-to-lot consistency of HER-2/neu expression.
We believe that assay specificity and the above characteristics are adequate to allow this ELISA to be considered for use in a mouse immunogenicity (potency) test of anthrax vaccines, and for the standardization of reagents.
